Antimitotic Agents: all 5,052 studies that test it

Page 15 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerCompletedNCT00658697Phase 2Results posted
• Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast CancerCompletedNCT00656669Not applicableResults posted
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00654836Phase 2Results posted
• A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung CancerCompletedNCT00653939Phase 2Results posted
• Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous SystemCompletedNCT00653068Phase 3Results posted
• Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLCCompletedNCT00647426Phase 2Results posted
• Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast CancerCompletedNCT00645333Phase 1/2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• A Phase I/II Trial of VR-CHOP in Lymphoma PatientsCompletedNCT00634179Phase 1/2Results posted
• Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerTerminatedNCT00634088Phase 1Results posted
• Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast CancerCompletedNCT00633464Phase 2Results posted
• Phase 1 Trial of Oral IxabepiloneTerminatedNCT00632424Phase 1Results posted
• Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast CancerCompletedNCT00630032Phase 3Results posted
• Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast CancerCompletedNCT00629499Phase 2Results posted
• Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of NeuronsCompletedNCT00627978Phase 2Results posted
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the CervixTerminatedNCT00626561Phase 2Results posted
• Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by SurgeryCompletedNCT00626405Phase 2Results posted
• Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast CancerTerminatedNCT00622466Phase 2Results posted
• Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCCompletedNCT00621049Phase 2Results posted
• MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00618917Phase 1/2Results posted
• A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast CancerCompletedNCT00618826Phase 2Results posted
• Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of TumorsCompletedNCT00618813Not applicableResults posted
• Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung CarcinomaTerminatedNCT00617656Phase 3Results posted
• Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung CancerTerminatedNCT00614484Phase 1/2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast CancerActive, not recruitingNCT00609791Phase 2Results posted
• Perioperative Therapy for Resectable Pancreatic CancerCompletedNCT00609336Phase 2Results posted
• A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With PaclitaxelTerminatedNCT00603941Phase 1/2Results posted
• Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00602797Phase 2Results posted
• 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus BevacizumabCompletedNCT00600340Phase 3Results posted
• Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)TerminatedNCT00599131Phase 2Results posted
• Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic MelanomaCompletedNCT00598507Phase 2Results posted
• Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT00594815Not applicableResults posted
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast CancerCompletedNCT00593827Phase 2Results posted
• Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTerminatedNCT00591149Phase 2Results posted
• Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNCT00589420Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT00588770Phase 3Results posted
• Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT00588237Phase 2Results posted
• Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate CancerCompletedNCT00587431Phase 2Results posted
• Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerCompletedNCT00585689Phase 2Results posted
• A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian CancerTerminatedNCT00585052Phase 2Results posted
• A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine CancerCompletedNCT00584857Phase 2Results posted
• A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With CancerTerminatedNCT00584012Phase 1Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Intravesicular Abraxane for Treatment-Refractory Bladder CancerCompletedNCT00583349Phase 1/2Results posted
• Optimized Intensity Modulated Irradiation for Head and Neck CancerCompletedNCT00580983Not applicableResults posted
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma PatientsCompletedNCT00577993Phase 3Results posted
• Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate CancerTerminatedNCT00577356Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.TerminatedNCT00576901Phase 2Results posted
• Trial for Locally Advanced Breast Cancer Using Vorinostat Plus ChemotherapyCompletedNCT00574587Phase 1/2Results posted
• Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin LymphomaCompletedNCT00574496Phase 2Results posted
• Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal CancerTerminatedNCT00573131Phase 2Results posted
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerCompletedNCT00569673Phase 2Results posted
• Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV MelanomaTerminatedNCT00568451Phase 2Results posted
• A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerCompletedNCT00568022Phase 1Results posted
• Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell CancerTerminatedNCT00566540Phase 2Results posted
• Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerActive, not recruitingNCT00565851Phase 3Results posted
• Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and AdolescentsCompletedNCT00565448Phase 2Results posted
• FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung CancerCompletedNCT00564733Phase 2Results posted
• Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsCompletedNCT00561795Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.CompletedNCT00559754Phase 2Results posted
• A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00558636Phase 3Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00558519Phase 2Results posted
• Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated HemangiomasTerminatedNCT00555464Phase 2Results posted
• Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular RetinoblastomaCompletedNCT00554788Phase 3Results posted
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00553462Phase 2Results posted
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
• Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedNCT00549848Phase 3Results posted
• Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast CancerTerminatedNCT00546364Phase 2Results posted
• Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast CancerCompletedNCT00546156Phase 2Results posted
• Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung CancerTerminatedNCT00545948Phase 2Results posted
• Vinflunine in Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00545766Phase 2Results posted
• A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.CompletedNCT00545688Phase 2Results posted
• Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLCTerminatedNCT00544648Phase 1/2Results posted
• Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck CancerCompletedNCT00544414Phase 2Results posted
• Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast CancerCompletedNCT00544167Not applicableResults posted
• Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001)CompletedNCT00543387Phase 1Results posted
• Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast CancerCompletedNCT00542451Phase 2Results posted
• Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast CancerTerminatedNCT00542191Phase 2Results posted
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00541099Phase 2Results posted
• Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver DysfunctionCompletedNCT00540982Phase 1/2Results posted
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00540514Phase 3Results posted
• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract CarcinomasTerminatedNCT00532441Phase 2Results posted
• Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyCompletedNCT00528866Phase 2Results posted
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryTerminatedNCT00526890Phase 2Results posted
• Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction PatientsCompletedNCT00526110Phase 1/2Results posted
• Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00524459Phase 2Results posted
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung CancerTerminatedNCT00520845Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.CompletedNCT00520403Phase 2Results posted
• Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCTerminatedNCT00519831Phase 2Results posted
• Prevention of Restenosis Following RevascularizationTerminatedNCT00518284Phase 2Results posted
• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction AdenocarcinomaCompletedNCT00515411Phase 2Results posted
• Papillary Serous Carcinoma of the EndometriumCompletedNCT00515073Phase 2Results posted
• A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)TerminatedNCT00514917Phase 3Results posted
• Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate CancerCompletedNCT00514540Phase 2Results posted
• Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial CarcinomaCompletedNCT00513786Phase 2Results posted
• Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerCompletedNCT00513695Phase 2Results posted
• Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by SurgeryCompletedNCT00513292Phase 3Results posted
• Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the PenisCompletedNCT00512096Phase 2Results posted
• Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian CancerCompletedNCT00511992Phase 2Results posted
• Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung CancerTerminatedNCT00509366Phase 2Results posted

← Antimitotic Agents overview